{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T01:18:52Z","timestamp":1747358332163},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCP"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.2174\/1574884708666131111192311","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T19:50:38Z","timestamp":1398109838000},"page":"148-156","source":"Crossref","is-referenced-by-count":9,"title":["The Interaction Potential of Retigabine (Ezogabine) with Other Antiepileptic Drugs"],"prefix":"10.2174","volume":"9","author":[{"given":"Debra","family":"Tompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Crean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/117804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T14:22:30Z","timestamp":1448288550000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1574-8847&volume=9&issue=2&spage=148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574884708666131111192311","relation":{},"ISSN":["1574-8847"],"issn-type":[{"value":"1574-8847","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}